For some chronic pain patients on opioids, especially those who have been taking opioids for many years, the risks of treatment must be balanced with the benefits. When the balance is in question, there should be an effort to taper, discontinue, or deprescribe in an effort to find the lowest effective dose and prevent withdrawal symptoms. What factors influence this decision? What do you need to know for your patients? Find out here as experts discuss the considerations and offer a holistic approach for safe, effective tapering.
At the completion of this application-based activity, participants will be able to:
- Identify clinical factors to consider when assessing whether an opioid tapering regimen is appropriate.
- Use soft skills to manage difficult conversations related to opioid therapy for chronic pain.
- Apply best practice tools for chronic pain management.
- Develop a novel, empathy-driven approach to chronic pain discussion focused on deescalating, discontinuing, or deprescribing opioid therapy.
Activity type: Application-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1.5 contact hour of CPE credit (0.15 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-20-024-H08-P
To obtain credit for completing Dialing Down Opioids in Five Steps, participants will need to watch the archived webinar, complete the assessment with a grade of 70% or better, complete the evaluation questions, and then CLAIM credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
APhA continuing pharmacy education policy provides you with two opportunities to successfully complete this continuing pharmacy education assessment. Please note that you will not be permitted to submit the assessment a third time. The current policy of the APhA Education Department is not to release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.Initial release date: April 1, 2020
Expiration date: March 21, 2023 - No credit granted after this date.
Dialing Down Opioids in Five Steps is an activity for pharmacists developed by the American Pharmacists Association. © 2020 American Pharmacists Association
Thomas Franko, PharmD and Lee Kral, PharmD and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association.
This learning product is a component of the APhA2020 Virtual Education package and is part of the Trending Topics in Ambulatory Care series.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
|Activity Number||Credit Amount||Accreditation Period|
|ACPE# 0202-0000-20-024-H08-P||0.15 CEUs||March 21, 2020 - March 21, 2023|